Immunosuppressive networks in the tumour environment and their therapeutic relevance (Q29619244)

Europe PubMed Central

title

Immunosuppressive networks in the tumour environment and their therapeutic relevance (English)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15776005

30 April 2017

author name string

Zou W

series ordinal

1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15776005

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15776005

30 April 2017

language of work or name

1 reference

30 April 2017

publication date

April 2005

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15776005

30 April 2017

published in

Nature Reviews Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15776005

30 April 2017

volume

5

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15776005

30 April 2017

page(s)

263-74

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15776005

30 April 2017

issue

4

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15776005

Cancer immunoediting: from immunosurveillance to tumor escape

30 April 2017

cites work

1 reference

Natural selection of tumor variants in the generation of "tumor escape" phenotypes

1 May 2017

1 reference

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

1 May 2017

1 reference

Dendritic cells and the control of immunity

1 May 2017

1 reference

Angiogenesis in cancer and other diseases

1 May 2017

1 reference

Peritoneal inflammation - A microenvironment for Epithelial Ovarian Cancer (EOC)

1 May 2017

1 reference

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 May 2017

1 reference

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

1 May 2017

1 reference

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade

1 May 2017

1 reference

B7x: a widely expressed B7 family member that inhibits T cell activation

1 May 2017

1 reference

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

1 May 2017

1 reference

The danger model: a renewed sense of self

1 May 2017

1 reference

Inflammation and cancer: back to Virchow?

1 May 2017

1 reference

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

1 May 2017

1 reference

B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

1 May 2017

1 reference

Involvement of chemokine receptors in breast cancer metastasis

1 May 2017

1 reference

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

1 May 2017

1 reference

Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation

1 May 2017

1 reference

1 May 2017

Inflammation and cancer

1 reference

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

1 May 2017

1 reference

A fresh look at tumor immunosurveillance and immunotherapy.

1 May 2017

1 reference

Strategies for immunotherapy of cancer

21 January 2018

1 reference

Does the immune system see tumors as foreign or self?

21 January 2018

1 reference

Cancer vaccines: between the idea and the reality

21 January 2018

1 reference

The use of dendritic cells in cancer immunotherapy

21 January 2018

1 reference

Modulating T-cell immunity to tumours: new strategies for monitoring T-cell responses

21 January 2018

1 reference

Manipulating dendritic cell biology for the active immunotherapy of cancer

21 January 2018

1 reference

Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patients

21 January 2018

1 reference

The immunotherapy of patients with ovarian cancer

21 January 2018

1 reference

Dendritic cell immunotherapy: mapping the way.

21 January 2018

1 reference

Mechanisms of MHC class I--restricted antigen processing

21 January 2018

1 reference

Antigen presentation to naive CD4 T cells in the lymph node.

21 January 2018

1 reference

Rapid cytotoxic T lymphocyte activation occurs in the draining lymph nodes after cutaneous herpes simplex virus infection as a result of early antigen presentation and not the presence of virus

21 January 2018

1 reference

CD8 T cell responses to infectious pathogens.

21 January 2018

1 reference

Close encounters of different kinds: dendritic cells and NK cells take centre stage

21 January 2018

1 reference

Immune surveillance against a solid tumor fails because of immunological ignorance

21 January 2018

1 reference

The use of HLA class I tetramers to design a vaccination strategy for melanoma patients

21 January 2018

1 reference

Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes

21 January 2018

1 reference

The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics

21 January 2018

1 reference

Plasmacytoid dendritic cells in immunity

21 January 2018

1 reference

Dendritic cells: a journey from laboratory to clinic

21 January 2018

1 reference

Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells

21 January 2018

1 reference

Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity

21 January 2018

1 reference

IDO and tolerance to tumors

21 January 2018

1 reference

In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas.

21 January 2018

1 reference

Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas

21 January 2018

1 reference

IL-6 production in ovarian carcinoma is associated with histiotype and biological characteristics of the tumour and influences local immunity

21 January 2018

1 reference

Prostanoids play a major role in the primary tumor-induced inhibition of dendritic cell differentiation

21 January 2018

1 reference

Exogenous but not endogenous prostanoids regulate cytokine secretion from murine bone marrow dendritic cells: EP2, DP, and IP but not EP1, EP3, and FP prostanoid receptors are involved

21 January 2018

1 reference

Induction of a CD4+ T regulatory type 1 response by cyclooxygenase-2-overexpressing glioma

21 January 2018

1 reference

Gangliosides from human melanoma tumors impair dendritic cell differentiation from monocytes and induce their apoptosis

21 January 2018

1 reference

Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells.

21 January 2018

1 reference

Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells

21 January 2018

1 reference

Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells

21 January 2018

1 reference

Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo

21 January 2018

1 reference

Genomic Organization and Expression Analysis of B7-H4, an Immune Inhibitory Molecule of the B7 Family

21 January 2018

1 reference

Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity

21 January 2018

1 reference

Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production

21 January 2018

1 reference

PD-1 blockade inhibits hematogenous spread of poorly immunogenic tumor cells by enhanced recruitment of effector T cells

21 January 2018

1 reference

B7-H4, a molecule of the B7 family, negatively regulates T cell immunity

21 January 2018

1 reference

B7S1, a novel B7 family member that negatively regulates T cell activation

21 January 2018

1 reference

Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection

21 January 2018

1 reference

Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase

21 January 2018

1 reference

CTLA-4-Ig regulates tryptophan catabolism in vivo.

21 January 2018

1 reference

Plasmacytoid dendritic cells prime IFN-γ-secreting melanoma-specific CD8 lymphocytes and are found in primary melanoma lesions

21 January 2018

1 reference

Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells

21 January 2018

1 reference

Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells

21 January 2018

1 reference

Gr-1+ myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation

21 January 2018

1 reference

Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism.

21 January 2018

1 reference

Tumor-induced immune dysfunctions caused by myeloid suppressor cells

21 January 2018

1 reference

Tumor-infiltrating macrophages induce apoptosis in activated CD8(+) T cells by a mechanism requiring cell contact and mediated by both the cell-associated form of TNF and nitric oxide.

21 January 2018

1 reference

L-arginine consumption by macrophages modulates the expression of CD3 zeta chain in T lymphocytes

21 January 2018

1 reference

Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses

21 January 2018

1 reference

Is cancer dangerous to the immune system?

21 January 2018

1 reference

Indomethacin inhibits the accumulation of tumor cells in mouse lungs and subsequent growth of lung metastases

21 January 2018

1 reference

Enhancing Radiotherapy With Cyclooxygenase-2 Enzyme Inhibitors: A Rational Advance?

21 January 2018

1 reference

Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells

21 January 2018

1 reference

AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor.

21 January 2018

1 reference

Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon

21 January 2018

1 reference

Immunotherapeutic uses of CpG oligodeoxynucleotides

21 January 2018

1 reference

CpG motifs: the active ingredient in bacterial extracts?

21 January 2018

1 reference

Antigen-induced regulatory T cells in autoimmunity

21 January 2018

1 reference

Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance

21 January 2018

1 reference

Autoreactive CD4+ T cells protect from autoimmune diabetes via bystander suppression using the IL-4/Stat6 pathway.

21 January 2018

1 reference

Natural versus adaptive regulatory T cells

21 January 2018

1 reference

In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines.

21 January 2018

1 reference

Elucidating the autoimmune and antitumor effector mechanisms of a treatment based on cytotoxic T lymphocyte antigen-4 blockade in combination with a B16 melanoma vaccine: comparison of prophylaxis and therapy

21 January 2018

1 reference

Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4.

21 January 2018

1 reference

Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses

21 January 2018

1 reference

Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells

21 January 2018

1 reference

Role for CD4(+) CD25(+) regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity

21 January 2018

1 reference

Infections as a major preventable cause of human cancer

21 January 2018

1 reference

Enhancement of antitumor immunity by CTLA-4 blockade

21 January 2018

1 reference

CTLA-4 blockade synergizes with tumor-derived granulocyte-macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma.

21 January 2018

1 reference

Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients

21 January 2018

1 reference

DAB(389)IL-2 (ONTAK): a novel fusion toxin therapy for lymphoma

21 January 2018

1 reference

Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells

21 January 2018

1 reference

Silencing of SOCS1 enhances antigen presentation by dendritic cells and antigen-specific anti-tumor immunity

21 January 2018

1 reference

Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy.

21 January 2018

1 reference

Activation of Dendritic Cells That Cross-Present Tumor-Derived Antigen Licenses CD8+ CTL to Cause Tumor Eradication

21 January 2018

1 reference

Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction

21 January 2018

1 reference

The promise of cancer vaccines

21 January 2018

1 reference

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report

31 March 2020

1 reference

Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naïve cells

31 March 2020

1 reference

Naïve CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation

31 March 2020

1 reference

Increasing tumor antigen expression overcomes "ignorance" to solid tumors via crosspresentation by bone marrow-derived stromal cells

31 March 2020

1 reference

Priming of naive T cells inside tumors leads to eradication of established tumors

31 March 2020

1 reference

Bone marrow as a priming site for T-cell responses to blood-borne antigen

31 March 2020

1 reference

Dendritic cell subsets differentially regulate angiogenesis in human ovarian cancer

31 March 2020

1 reference

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells

31 March 2020

1 reference

Phenotypic characterisation of the dendritic cell infiltrate in prostate cancer

31 March 2020

1 reference

Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells

31 March 2020

1 reference

B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function

31 March 2020

1 reference

Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A

31 March 2020

1 reference

Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer

31 March 2020

1 reference

Inflammation and necrosis promote tumour growth

31 March 2020

1 reference

Chemopreventive efficacies of aspirin and sulindac against lung tumorigenesis in A/J mice

31 March 2020

1 reference

CD4+CD25+ regulatory T cells that secrete TGFbeta and IL-10 are preferentially induced by a vaccine vector

31 March 2020

1 reference

Regulatory T-cell response and tumor vaccine-induced cytotoxic T lymphocytes in human melanoma

31 March 2020

1 reference

Fatal attraction: tumors beckon regulatory T cells

31 March 2020

1 reference

CD4+ CD25+ suppressor T cells: more questions than answers

31 March 2020

1 reference

Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation

31 March 2020

1 reference

Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma

31 March 2020

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15776005

31 March 2020

Identifiers

2 references

30 April 2017

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

668835

1020273083

0 references

668835

1 reference

Consolidated OpenCitations Corpus – April 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15776005

2 references

30 April 2017

Consolidated OpenCitations Corpus – April 2017